Advertisement

Topics

CRISPR-Based Drugmaker Raises $80 Million

02:00 EDT 28 Sep 2018 | Forbes

KSQ Therapeutics, a Cambridge, Mass.-based biotechnology that uses the genetic-engineering tool CRISPR to develop new drugs, has raised $80 million, it's second big raise in as many years. KSQ raised $76 million last October.

Original Article: CRISPR-Based Drugmaker Raises $80 Million

NEXT ARTICLE

More From BioPortfolio on "CRISPR-Based Drugmaker Raises $80 Million"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...